// Evidence Grader
Claim grades, A through F
Every major genomics claim in this course gets a transparent grade — from clinically established interventions to outright misleading marketing. Use this dashboard to audit what's settled, what's preliminary, and what's hype.
A
Clinically established
B
Supported, context-specific
C
Promising, preliminary
D
Plausible, unproven
E
Popular, weak support
F
Misleading or false
Filtered:← Back to module
B
Partial reprogramming (cyclic OSK) can reverse epigenetic age in human cells
Sarkar 2020, Lu 2020, Browder 2022 — strong cell/mouse evidence; no published human in-vivo trials yet.
Module 07 · The Epigenome and Methylation Clocks →